This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Feb;10(1):15.

doi: 10.1136/ebmh.10.1.15.

Risperidone improves symptoms in people who are hospitalised during an acute exacerbation of schizophrenia

Robert Chaplin¹

Affiliations

PMID: 17255384
DOI: 10.1136/ebmh.10.1.15

Comment

Risperidone improves symptoms in people who are hospitalised during an acute exacerbation of schizophrenia

Robert Chaplin. Evid Based Ment Health. 2007 Feb.

. 2007 Feb;10(1):15.

doi: 10.1136/ebmh.10.1.15.

Author

Robert Chaplin¹

Affiliation

¹ Warneford Hospital, Oxford, UK.

PMID: 17255384
DOI: 10.1136/ebmh.10.1.15

No abstract available

PubMed Disclaimer

Comment on

A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
Potkin SG, Gharabawi GM, Greenspan AJ, Mahmoud R, Kosik-Gonzalez C, Rupnow MF, Bossie CA, Davidson M, Burtea V, Zhu Y, Trivedi JK. Potkin SG, et al. Schizophr Res. 2006 Jul;85(1-3):254-65. doi: 10.1016/j.schres.2006.03.027. Epub 2006 Jun 21. Schizophr Res. 2006. PMID: 16797162 Clinical Trial.

Similar articles

Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
Lane HY, Chang YC, Liu YC, Chiu CC, Tsai GE. Lane HY, et al. Arch Gen Psychiatry. 2005 Nov;62(11):1196-204. doi: 10.1001/archpsyc.62.11.1196. Arch Gen Psychiatry. 2005. PMID: 16275807 Clinical Trial.
Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
Addington DE, Pantelis C, Dineen M, Benattia I, Romano SJ. Addington DE, et al. J Clin Psychiatry. 2004 Dec;65(12):1624-33. doi: 10.4088/jcp.v65n1207. J Clin Psychiatry. 2004. PMID: 15641867 Clinical Trial.
[Risperidone in the treatment of acute exacerbation of schizophrenia symptoms].
Gutiérrez M, Gibert J, Bobes J, Herráiz ML, Fernández A. Gutiérrez M, et al. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1998 Mar-Apr;26(2):83-9. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1998. PMID: 9595821 Clinical Trial. Spanish.
Risperidone. A pharmacoeconomic review of its use in schizophrenia.
Foster RH, Goa KL. Foster RH, et al. Pharmacoeconomics. 1998 Jul;14(1):97-133. doi: 10.2165/00019053-199814010-00009. Pharmacoeconomics. 1998. PMID: 10182198 Review.
Olanzapine: an updated review of its use in the management of schizophrenia.
Bhana N, Foster RH, Olney R, Plosker GL. Bhana N, et al. Drugs. 2001;61(1):111-61. doi: 10.2165/00003495-200161010-00011. Drugs. 2001. PMID: 11217867 Review.

See all similar articles

Cited by

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia.
Bighelli I, Rodolico A, Siafis S, Samara MT, Hansen WP, Salomone S, Aguglia E, Cutrufelli P, Bauer I, Baeckers L, Leucht S. Bighelli I, et al. Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD014383. doi: 10.1002/14651858.CD014383.pub2. Cochrane Database Syst Rev. 2022. PMID: 36042158 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.